DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
A phase III randomized, double-blind trial of chemoembolization with or without sorafenib in unresectable hepatocellular carcinoma (HCC) in patients with and without vascular invasion.
Available at:
http://clinicaltrials.gov/ct2/show/NCT01004978 . Accessed February 23, 2012
We do not assume any responsibility for the contents of the web pages of other providers.